Spectranetics Corporation, The – Trademark Portfolio
Entity Type: 03
Spectranetics Corporation, The holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELCA and CVX-300. The owner is based in Colorado Springs, CO.
9965 Federal Drive
Colorado Springs, CO 80921
Showing of trademarks Trademarks
Trademark Classifications
Spectranetics Corporation, The's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Spectranetics Corporation, The have?
Spectranetics Corporation, The has 17 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 11 cancelled.
What trademark classes does Spectranetics Corporation, The file in?
Spectranetics Corporation, The files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Spectranetics Corporation, The's most well-known trademarks?
Spectranetics Corporation, The's registered trademark portfolio includes well-known marks such as ELCA and CVX-300. These are among 2 currently registered trademarks in the portfolio.
What is Spectranetics Corporation, The's trademark registration success rate?
Spectranetics Corporation, The has a 12% trademark registration rate, with 2 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.